U.S. flag

An official website of the United States government, Department of Justice.

NCJRS Virtual Library

The Virtual Library houses over 235,000 criminal justice resources, including all known OJP works.
Click here to search the NCJRS Virtual Library

Characteristics of Indigenous Injecting Drug Users in Sydney: Gender, Prison History and Treatment Experiences

NCJ Number
194138
Author(s)
Carolyn Day; Kate Dolan
Date Published
October 2001
Length
6 pages
Annotation
This study identified the characteristics of samples of Indigenous and non-Indigenous injecting drug users (IDU's) in Sydney (Australia) to determine any differences between the two groups.
Abstract
Three types of cross-sectional studies of IDU's recruited in Sydney were reviewed. Study 2 involved four cross-sectional studies repeated over 4 years and collapsed into one dataset. Data for studies 1 and 3 were collected over a discrete period. Similar recruitment methods were used in all three studies; i.e., participants were either current IDU's, heroin users, or in a methadone maintenance program. No particular ethnic group was targeted, and all participants were volunteers. All interviews were conducted face-to-face with trained interviewers. Data for study 1 were collected in 2000-2001 with a total sample of 399 IDU's (17 percent Indigenous). Data for study 2 were obtained in 1997-2000 for 636 IDU's (19 percent Indigenous); and data for study 3 were collected in 1999 from 150 IDU's (15 percent Indigenous). The studies found that there were few differences between Indigenous and non-Indigenous IDU's; however, there were more female Indigenous IDU's than non-Indigenous IDU's in all studies; this was significant in study 1 (56 percent compared with 33 percent). In each study the lifetime prevalence of incarceration was higher in the Indigenous subjects than the non-Indigenous subjects; however, this difference reached significance only in study 2 (68 percent compared with 49 percent). Indigenous IDU's were more likely to report heroin as their main drug than non-Indigenous IDU's in all studies. This difference reached significance in study 1 (87 percent compared with 76 percent). Indigenous IDU's were less likely to report using a needle or syringe after another person in the last month than non-Indigenous IDU's; however, this difference was not significant in any of the studies. These findings suggest that services may need to be more attuned to the needs of Indigenous IDU's; barriers to treatment must be addressed, along with other IDU needs, such as blood-borne virus testing. Given the high rate of incarceration reported by Indigenous IDU's, prison may be an ideal opportunity to promote treatment and blood-borne virus testing and to address some of the barriers identified by Indigenous IDU's. 4 tables and 9 references